TY - JOUR
T1 - Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis
AU - Millet, Arnaud
AU - Martin, Katherine R.
AU - Bonnefoy, Francis
AU - Saas, Philippe
AU - Mocek, Julie
AU - Alkan, Manal
AU - Terrier, Benjamin
AU - Kerstein, Anja
AU - Tamassia, Nicola
AU - Satyanarayanan, Senthil Kumaran
AU - Ariel, Amiram
AU - Ribeil, Jean Antoine
AU - Guillevin, Loïc
AU - Cassatella, Marco A.
AU - Mueller, Antje
AU - Thieblemont, Nathalie
AU - Lamprecht, Peter
AU - Mouthon, Luc
AU - Perruche, Sylvain
AU - Witko-Sarsat, Véronique
PY - 2015/11/2
Y1 - 2015/11/2
N2 - Granulomatosis with polyangiitis (GPA) is a systemic necrotizing vasculitis that is associated with granulomatous inflammation and the presence of anti-neutrophil cytoplasmic antibodies (ANCAs) directed against proteinase 3 (PR3). We previously determined that PR3 on the surface of apoptotic neutrophils interferes with induction of antiinflammatory mechanisms following phagocytosis of these cells by macrophages. Here, we demonstrate that enzymatically active membrane-associated PR3 on apoptotic cells triggered secretion of inflammatory cytokines, including granulocyte CSF (G-CSF) and chemokines. This response required the IL-1R1/MyD88 signaling pathway and was dependent on the synthesis of NO, as macrophages from animals lacking these pathways did not exhibit a PR3-associated proinflammatory response. The PR3-induced microenvironment facilitated recruitment of inflammatory cells, such as macrophages, plasmacytoid DCs (pDCs), and neutrophils, which were observed in close proximity within granulomatous lesions in the lungs of GPA patients. In different murine models of apoptotic cell injection, the PR3-induced microenvironment instructed pDC-driven Th9/Th2 cell generation. Concomitant injection of anti-PR3 ANCAs with PR3-expressing apoptotic cells induced a Th17 response, revealing a GPA-specific mechanism of immune polarization. Accordingly, circulating CD4+ T cells from GPA patients had a skewed distribution of Th9/Th2/Th17. These results reveal that PR3 disrupts immune silencing associated with clearance of apoptotic neutrophils and provide insight into how PR3 and PR3-targeting ANCAs promote GPA pathophysiology.
AB - Granulomatosis with polyangiitis (GPA) is a systemic necrotizing vasculitis that is associated with granulomatous inflammation and the presence of anti-neutrophil cytoplasmic antibodies (ANCAs) directed against proteinase 3 (PR3). We previously determined that PR3 on the surface of apoptotic neutrophils interferes with induction of antiinflammatory mechanisms following phagocytosis of these cells by macrophages. Here, we demonstrate that enzymatically active membrane-associated PR3 on apoptotic cells triggered secretion of inflammatory cytokines, including granulocyte CSF (G-CSF) and chemokines. This response required the IL-1R1/MyD88 signaling pathway and was dependent on the synthesis of NO, as macrophages from animals lacking these pathways did not exhibit a PR3-associated proinflammatory response. The PR3-induced microenvironment facilitated recruitment of inflammatory cells, such as macrophages, plasmacytoid DCs (pDCs), and neutrophils, which were observed in close proximity within granulomatous lesions in the lungs of GPA patients. In different murine models of apoptotic cell injection, the PR3-induced microenvironment instructed pDC-driven Th9/Th2 cell generation. Concomitant injection of anti-PR3 ANCAs with PR3-expressing apoptotic cells induced a Th17 response, revealing a GPA-specific mechanism of immune polarization. Accordingly, circulating CD4+ T cells from GPA patients had a skewed distribution of Th9/Th2/Th17. These results reveal that PR3 disrupts immune silencing associated with clearance of apoptotic neutrophils and provide insight into how PR3 and PR3-targeting ANCAs promote GPA pathophysiology.
UR - http://www.scopus.com/inward/record.url?scp=84946762057&partnerID=8YFLogxK
U2 - 10.1172/JCI78182
DO - 10.1172/JCI78182
M3 - Article
C2 - 26436651
AN - SCOPUS:84946762057
SN - 0021-9738
VL - 125
SP - 4107
EP - 4121
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 11
ER -